Terms: = Prostate cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Treatment
27 results:
1. A Homodimer of Withaferin A Formed by Base-Promoted Elimination of Acetic Acid from 27-
Wijeratne EMK; Xu YM; Padumadasa C; Astashkin AV; Gunatilaka AAL
J Nat Prod; 2024 Mar; 87(3):583-590. PubMed ID: 38414352
[TBL] [Abstract] [Full Text] [Related]
2. Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo.
Paindelli C; Parietti V; Barrios S; Shepherd P; Pan T; Wang WL; Satcher RL; Logothetis CJ; Navone N; Campbell MT; Mikos AG; Dondossola E
Acta Biomater; 2024 Apr; 178():83-92. PubMed ID: 38387748
[TBL] [Abstract] [Full Text] [Related]
3. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI
Nezir AE; Bolat ZB; Ozturk N; Kocak P; Zemheri E; Gulyuz S; Ozkose UU; Yilmaz O; Vural I; Bozkır A; Sahin F; Telci D
Amino Acids; 2023 Aug; 55(8):1023-1037. PubMed ID: 37318626
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
5. Preparing Future Medicine Physicians to Care for cancer Survivors: Project ECHO® in a Novel Internal Medicine and Family Medicine Residency Curriculum.
Choi Y; Chodoff AC; Brown K; Murillo LA; Nesfeder J; Bugayong MT; Peairs KS
J Cancer Educ; 2023 Apr; 38(2):608-617. PubMed ID: 35366218
[TBL] [Abstract] [Full Text] [Related]
6. Polymeric Nanoparticles for the treatment of prostate cancer- Technological Prospecting and Critical Analysis.
de Oliveira CR; Droppa-Almeida D; Padilha FF; de Souza RR; de Albuquerque-Júnior RLC
Recent Pat Nanotechnol; 2023; 17(1):8-14. PubMed ID: 35100962
[TBL] [Abstract] [Full Text] [Related]
7. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
[TBL] [Abstract] [Full Text] [Related]
8. Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer.
Zhang Y; Wang Y; Meng L; Huang Q; Zhu Y; Cui W; Cheng Y; Liu R
J Nanobiotechnology; 2021 Jan; 19(1):17. PubMed ID: 33422073
[TBL] [Abstract] [Full Text] [Related]
9. The Utilization of Poly(2-ethyl-2-oxazoline)-b-Poly(ε-caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to prostate cancer.
Kocak P; Oz UC; Bolat ZB; Ozkose UU; Gulyuz S; Tasdelen MA; Yilmaz O; Bozkir A; Sahin F; Telci D
Macromol Biosci; 2021 Feb; 21(2):e2000287. PubMed ID: 33191572
[TBL] [Abstract] [Full Text] [Related]
10. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic prostate cancer Therapy.
Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
[TBL] [Abstract] [Full Text] [Related]
11. Characterization and in vitro antitumor activity of polymeric nanoparticles loaded with Uncaria tomentosa extract.
Ribeiro AF; Santos JF; Mattos RR; Barros EGO; Nasciutti LE; Cabral LM; Sousa VP
An Acad Bras Cienc; 2020; 92(1):e20190336. PubMed ID: 32321026
[TBL] [Abstract] [Full Text] [Related]
12. Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging.
Rigo M; Mazzola R; Napoli G; Giaj-Levra N; Figlia V; Nicosia L; Ricchetti F; Tomasini D; Bonù ML; Cuccia F; Bellorofonte C; Alongi F
Radiol Med; 2020 May; 125(5):491-499. PubMed ID: 32077006
[TBL] [Abstract] [Full Text] [Related]
13. Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast cancer Models with a Distinct Mechanism of Action.
Yu Z; He S; Wang D; Patel HK; Miller CP; Brown JL; Hattersley G; Saeh JC
Clin Cancer Res; 2017 Dec; 23(24):7608-7620. PubMed ID: 28974548
[No Abstract] [Full Text] [Related]
14. Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer.
Liu T; Huang Q
Int J Pharm; 2016 Sep; 511(2):1002-11. PubMed ID: 27521701
[TBL] [Abstract] [Full Text] [Related]
15. Licoricidin, an Active Compound in the Hexane/Ethanol Extract of Glycyrrhiza uralensis, Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells.
Park SY; Kwon SJ; Lim SS; Kim JK; Lee KW; Park JH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314329
[TBL] [Abstract] [Full Text] [Related]
16. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
[TBL] [Abstract] [Full Text] [Related]
17. PSMA ligand conjugated pcl-PEG polymeric micelles targeted to prostate cancer cells.
Jin J; Sui B; Gou J; Liu J; Tang X; Xu H; Zhang Y; Jin X
PLoS One; 2014; 9(11):e112200. PubMed ID: 25386942
[TBL] [Abstract] [Full Text] [Related]
18. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.
Sanna V; Siddiqui IA; Sechi M; Mukhtar H
Mol Pharm; 2013 Oct; 10(10):3871-81. PubMed ID: 23968375
[TBL] [Abstract] [Full Text] [Related]
19. Hypoxia preconditioning of mesenchymal stromal cells enhances PC3 cell lymphatic metastasis accompanied by VEGFR-3/CCR7 activation.
Huang X; Su K; Zhou L; Shen G; Dong Q; Lou Y; Zheng S
J Cell Biochem; 2013 Dec; 114(12):2834-41. PubMed ID: 23939705
[TBL] [Abstract] [Full Text] [Related]
20. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract] [Full Text] [Related]
[Next]
